Full Text
Budget Impact of the Introduction of Subcutaneous Rituximab to U.S. Health Plans

Abstract

Authors

RN Hansen CJ Wallick SD Sullivan

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×